|
ACTR3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.202400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.786640E-01 |
| Normal-vs-Stage2 |
3.267500E-02 |
| Normal-vs-Stage3 |
6.184400E-03 |
| Normal-vs-Stage4 |
1.764460E-02 |
| Stage1-vs-Stage2 |
6.107800E-02 |
| Stage1-vs-Stage3 |
1.484350E-02 |
| Stage1-vs-Stage4 |
2.052200E-02 |
| Stage2-vs-Stage3 |
8.517200E-01 |
| Stage2-vs-Stage4 |
5.191800E-01 |
| Stage3-vs-Stage4 |
5.951200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.398200E-02 |
| Normal-vs-AfricanAmerican |
2.657800E-02 |
| Normal-vs-Asian |
1.708020E-01 |
| Caucasian-vs-AfricanAmerican |
5.541200E-01 |
| Caucasian-vs-Asian |
1.830620E-01 |
| AfricanAmerican-vs-Asian |
3.071000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.037640E-01 |
| Normal-vs-Female |
1.78089999999242E-05 |
| Male-vs-Female |
1.432240E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.626210E-01 |
| Normal-vs-Extreme_Weight |
3.644600E-01 |
| Normal-vs-Obese |
4.760100E-03 |
| Normal-vs-Extreme_Obese |
9.425200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.814400E-01 |
| Normal_Weight-vs-Obese |
1.920190E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.003200E-01 |
| Extreme_Weight-vs-Obese |
2.132300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.311800E-01 |
| Obese-vs-Extreme_Obese |
1.500630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.650300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.436000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.766570E-01 |
| Normal-vs-Age(81-100Yrs) |
7.732200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.203400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816130E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.278400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.108150E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.843800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.637600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.471800E-02 |
| Normal-VS-Type2 PRCC |
3.469700E-02 |
| Normal-VS-KIRP CIMP |
8.37710001366787E-09 |
| Normal-VS-Unclassified PRCC |
1.959540E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.668600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.35350000008661E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.850390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.96539999999901E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
3.952800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.759100E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.326600E-01 |
| Normal-vs-N1 |
9.67610000000008E-05 |
| Normal-vs-N2 |
3.154100E-02 |
| N0-vs-N1 |
3.975200E-04 |
| N0-vs-N2 |
1.735590E-01 |
| N1-vs-N2 |
4.441000E-01 |
|
|
